title: Steady-state and dynamic behavior of ventricular repolarization and refractoriness in the dog: the effect of multiple cycle length changes and d-sotalol administration.
abstract: In anesthetized dogs with chronic, complete AV block we studied the characteristics of ventricular repolarization and refractoriness. Therefore, we determined: (1) steady-state values of ventricular effective refractory period (VERP), action potential duration (APD), and stimulus T interval (STI) before and after d-sotalol treatment at various pacing cycle lengths (PCLs); and (2) the dynamics of VERP, APD, and STI before and after d-sotalol treatment after the abrupt PCL decreases. VERP, APD, and STI showed a normal frequency dependency. All three parameters increased significantly after d-sotalol administration. During steady-state and dynamic measurements, STI was always longer than APD and APD was always longer than VERP in an individual animal, irrespective of PCL and conditions. Standard deviations of steady-state and dynamic values indicated a considerable interindividual variation. However, the dynamics of VERP, APD, and STI after an abrupt decrease in PCL were highly correlated (linear regression analysis: r2 > or = 0.93). The best mathematical model to describe these dynamics was a bi-exponential model (r2 > or = 0.98) with a very short first and a much longer second time constant. We found that there was a very consistent relation between VERP, APD, and STI, not only during steady-state but also in the dynamic situation after various abrupt PCL decreases. This relation does not change after the administration of d-sotalol. Therefore, STI could be used to predict steady-state and dynamic values of VERP and APD. Since STI can be made available online in implantable pacing systems this could lead to the development of new features in these devices.
authors.affiliation: Department of Cardiology, Cardiovascular Research Institute Maastricht, University Hospital Maastricht, The Netherlands.
authors.forename: H M
authors.initials: HM
authors.lastname: Leerssen
authors.forename: M A
authors.initials: MA
authors.lastname: Vos
authors.forename: K
authors.initials: K
authors.lastname: den Dulk
authors.forename: J
authors.initials: J
authors.lastname: van der Zande
authors.forename: A M
authors.initials: AM
authors.lastname: Muijtjens
authors.forename: M J
authors.initials: MJ
authors.lastname: Begemann
authors.forename: H J
authors.initials: HJ
authors.lastname: Wellens
mesh_terms: D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D002304:Cardiac Pacing, Artificial; D004285:Dogs; D004562:Electrocardiography / Q000187:drug effects*; D015716:Electrocardiography, Ambulatory / Q000295:instrumentation; D005260:Female; D006327:Heart Block / Q000503:physiopathology*; D006352:Heart Ventricles / Q000187:drug effects* / Q000503:physiopathology; D008297:Male; D009862:Online Systems; D012815:Signal Processing, Computer-Assisted / Q000295:instrumentation; D013015:Sotalol / Q000494:pharmacology*
chemical_list: D000889:Anti-Arrhythmia Agents; D013015:Sotalol